Can China Biologic Products Holdings, Inc. (NASDAQ:CBPO) Thread the Needle? Technicals at a Glance

Stock market investing can sometimes cause investors heads to spin. Following stocks on a daily basis, it is plain to see the amount of coverage that follows certain companies. This non-stop barrage of information may eventually become overwhelming for the novice investor. Filtering through all the data may involve taking a look at a company or stock from multiple angles. There are many investors out there that preach strictly following fundamental data. There are others that swear by the technical analysis. Many investors will opt to employ a research strategy that involves pieces of the two approaches. Knowing every little detail about a company may not be overly necessary, but it may help provide a bit more direction when navigating the stock market maze. Investors who put in the time to study all the fundamentals may want to also start watching the charts on stock that they are thinking about adding to the portfolio. Making sure that no stone is left unturned when examining a stock may end up being the difference between a big winner and a big loser.

As we close in on the end of the calendar year, investors may be trying to visualize potential trades for the New Year. There are many professionals that believe that there is still plenty of room for stocks to run even at current levels. Preparing the game plan for the next few quarters may give the investor some new ideas. Staying focused and maintaining discipline may help guide the investor to unchartered territory in the coming months. Tracking market events from multiple angles may also help provide some enhanced perspective.  

China Biologic Products Holdings, Inc. (NASDAQ:CBPO), of the Healthcare sector recently touched $99.95 based on a recent trade, indicating movement of -0.77%. Analysts are predicting earnings per share growth of -13.70% for the current year. The earnings per share growth over the next five years are expected to be 9.13%. China Biologic Products Holdings, Inc. has had earnings per share growth of 11.00% over the past five years. 

Currently the return on equity is 8.40% and its debt to equity is 0.00. China Biologic Products Holdings, Inc. has a total market cap of $3833.08, a gross margin of 67.10% while the profit margin is 28.80% and the ROI is 7.00%.


The stats on China Biologic Products Holdings, Inc. (NASDAQ:CBPO) are currently as follows. The weekly performance is -2.56%, and the quarterly performance is at 9.28%. The monthly performance is 4.14% and the yearly performance is 4.14%. The performance for Year to Date (YTD) is 31.67%.

China Biologic Products Holdings, Inc. has posted a trailing 12 months earnings per share of $3.59 and the earnings per share growth for this year is expected to be -13.70%. The ROI is 7.00% and the return on equity for China Biologic Products Holdings, Inc. stated earlier, is currently at 8.40% .The return on assets (ROA) for China Biologic Products Holdings, Inc. is 7.20%. 

Earnings per share (EPS) the amount of income that “belongs” to each share of common stock. This is a valuable tool that investors use to determine the value and projected value of a stock.  Earnings per share is generally reported in annualized form from the most recent fiscal year. To determine the value, the average number of shares outstanding is usually calculated by averaging the number of shares at the beginning of the fiscal period and the number of shares at the end of the period. 


The technical stats for China Biologic Products Holdings, Inc. are as follows. China Biologic Products Holdings, Inc. (NASDAQ:CBPO) is trading 66.36% away from the stock’s 52-week low and -3.43% off of the 52-week high. Current levels place the company 0.20% away from it’s 20-day simple moving average. The average volume stands around 179305. Trading volume is a hugely important consideration for any investor.  By watching how many shares are trading hands and looking for any changes in that activity, trading opportunities can be spotted along with a deeper understanding of the reliability of other indicators on the stock.  A significant increase in trading volume means that more than double the average amount of stocks are moving.  When volume is decreased significantly, it may indicate there is an issue that shareholders should watch out for.  It’s also important to take into consideration how long the unusual volume sustains for.  If it’s only the one trading day, it can be dismissed as an anomaly.

The current stock levels place it 12.43% away from the 200 day moving average. China Biologic Products Holdings, Inc. has a beta of 1.19 and the weekly and monthly volatility stands at 2.03% and 1.93% respectively. The simple moving average is the most common method used to calculate the moving average of prices.  It takes the sum of all of the past closing prices over a specific time period and divides the result by the number of prices used in the calculation.  Increasing the number of time periods in the calculation is an effective way to ascertain the strength of the long-term trend and/or the likelihood that it might reverse.  Some argue that this type of average is not necessarily useful because each data point in the series has the exact same impact on the result no matter where it occurs in the sequence.

Beta is used to measure a stock’s price volatility relative to the market. A stock with a beta of “0” indicates that its price is not correlated with the market. A positive beta indicates that the stock follows the market. A negative beta means that the stock inversely follows the market, decreasing in value when the market goes up. 

Price Earnings Ratio

The price/earnings ratio (P/E) for China Biologic Products Holdings, Inc. is 27.86 and the forward P/E ratio stands at 20.95. The price to sales growth is 7.67. The price/earnings ratio (P/E) is a market prospect ratio which calculates the value of a stock relative to its earnings. On other words, the P/E ratio is and indicator of what investors are will to pay for a stock relative to its earnings.  A firm with a high P/E ratio typically indicates that investors are willing to pay a premium for the stock and higher performance in future quarters would be anticipated. Going a step further we can also look at the PEG ratio of a company.  A stock’s price/earnings ratio divided by its year-over-year earnings growth rate. In general, the lower the PEG, the better the value, because the investor would be paying less for each unit of earnings growth.

Investors have plenty to keep up with when following day to day business news. Sifting through the headlines can be cumbersome, and figuring out which data to pay attention to can be very time consuming. News events can play a big role in the investing world. Big news has the ability to push a stock up or down. Sometimes the move may be justified, and other times it may not be. Disciplined investors are usually skilled at determining which information to focus on. Overreactions can play a large role in determining the long-term health of a portfolio. Investors often have to understand that a great stock can see periods of decline just as a weak stock may experience periods of strength. Putting in the research hours can help the investor prepare for opportunities when they spot unusual action in the stock market.

Disclaimer: The views of the author are in no way suggesting whether or not to buy a stock.  Data is provided by Yahoo Finance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *